Literature DB >> 7313999

Treatment of pulmonary infections caused by mycobacteria of the Mycobacterium avium-intracellulare complex.

A M Hunter, I A Campbell, P A Jenkins, A P Smith.   

Abstract

Sixty-four patients with pulmonary infection caused by mycobacteria of the M avium-intracellulare complex have been reviewed. Patients who were asymptomatic on presentation often had a benign course but some developed progressive disease. Symptomatic patients who were not treated usually deteriorated. Various treatment regimens were used. Successful treatment was achieved in the majority of patients using a combination of isoniazid, rifampicin, and either ethambutol or streptomycin given for 24 months. Other forms of treatment given including multiple drug regimens were not as effective.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7313999      PMCID: PMC471504          DOI: 10.1136/thx.36.5.326

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  4 in total

Review 1.  Nontuberculous mycobacteria and associated diseases.

Authors:  E Wolinsky
Journal:  Am Rev Respir Dis       Date:  1979-01

2.  Pulmonary disease due to Mycobacterium intracellulare.

Authors:  H Yeager; J W Raleigh
Journal:  Am Rev Respir Dis       Date:  1973-09

3.  Long-term results of medical treatment in Mycobacterium intracellulare infection.

Authors:  A K Dutt; W W Stead
Journal:  Am J Med       Date:  1979-09       Impact factor: 4.965

4.  Pulmonary mycobacterial infections due to Mycobacterium intracellulare-avium complex. Clinical features and course in 100 consecutive cases.

Authors:  D Y Rosenzweig
Journal:  Chest       Date:  1979-02       Impact factor: 9.410

  4 in total
  18 in total

1.  Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  2000-03       Impact factor: 9.139

Review 2.  Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections.

Authors:  E Nuermberger; J Grosset
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-13       Impact factor: 3.267

Review 3.  Treatment of pulmonary disease caused by opportunist mycobacteria.

Authors:  J Banks
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

Review 4.  Risk-benefit assessment of therapies for Mycobacterium avium complex infections.

Authors:  D E Griffith
Journal:  Drug Saf       Date:  1999-08       Impact factor: 5.606

Review 5.  Susceptibility testing of Mycobacterium avium complex isolates.

Authors:  L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

6.  Tenosynovitis of the hand caused by Mycobacterium terrae.

Authors:  B Petrini; G Svartengren; S E Hoffner; G Unge; O Widström
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-08       Impact factor: 3.267

7.  Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium.

Authors:  S E Hoffner; S B Svenson; G Källenius
Journal:  Eur J Clin Microbiol       Date:  1987-10       Impact factor: 3.267

Review 8.  Infections caused by opportunist mycobacteria: a review.

Authors:  J M Grange; M D Yates
Journal:  J R Soc Med       Date:  1986-04       Impact factor: 5.344

9.  Pulmonary infection with opportunist mycobacteria on Merseyside 1974-1983.

Authors:  H W Clague; E H el-Ansary; C A Hopkins; C Roberts
Journal:  Postgrad Med J       Date:  1986-05       Impact factor: 2.401

10.  Clinical review of pulmonary disease caused by Mycobacterium xenopi.

Authors:  M J Smith; K M Citron
Journal:  Thorax       Date:  1983-05       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.